Sarepta Therapeutics, Inc.
SRPT
$18.84
-$0.29-1.52%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 65.06M | -713.41M | -271.51M | -57.96M | -248.39M |
| Total Depreciation and Amortization | 45.14M | 44.52M | 49.72M | 41.08M | 38.96M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 291.52M | 385.37M | 363.62M | 289.98M | 331.05M |
| Change in Net Operating Assets | -226.44M | 78.04M | -386.47M | -573.86M | -668.77M |
| Cash from Operations | 175.28M | -205.48M | -244.64M | -300.75M | -547.15M |
| Capital Expenditure | -60.40M | -101.97M | -136.46M | -150.79M | -148.16M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 286.83M | 171.61M | 874.02M | 527.12M | 393.75M |
| Cash from Investing | 226.43M | 69.64M | 737.55M | 376.33M | 245.59M |
| Total Debt Issued | 250.00M | -- | -- | -- | -- |
| Total Debt Repaid | -409.38M | -162.59M | -127.52M | -3.58M | -3.28M |
| Issuance of Common Stock | 23.26M | 38.70M | 42.11M | 34.65M | 73.07M |
| Repurchase of Common Stock | -25.01M | -25.01M | -25.01M | -25.01M | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -19.45M | -19.45M | 30.29M | 45.35M | 45.35M |
| Cash from Financing | -180.57M | -168.34M | -80.15M | 51.40M | 115.14M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 221.13M | -304.18M | 412.77M | 126.98M | -186.42M |